{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:47:06Z","timestamp":1793332026581,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.eururo.2014.08.010","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T16:01:07Z","timestamp":1408550467000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"title":["Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer"],"prefix":"10.1016","volume":"68","author":[{"given":"Tobias","family":"Nordstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Assel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Lilja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Gr\u00f6nberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2014.08.010_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.1993.03500010067033","article-title":"The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer","volume":"269","author":"Oesterling","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2014.08.010_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0090-4295(99)80158-7","article-title":"Age-specific reference ranges for serum prostate-specific antigen","volume":"46","author":"Anderson","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2014.08.010_bib0015","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1001\/archinte.1996.00440200080010","article-title":"Predictive properties of serum-prostate-specific antigen testing in a community-based setting","volume":"156","author":"Jacobsen","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eururo.2014.08.010_bib0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2490-9-14","article-title":"A systematic review of the diagnostic accuracy of prostate specific antigen","volume":"9","author":"Harvey","year":"2009","journal-title":"BMC Urol"},{"key":"10.1016\/j.eururo.2014.08.010_bib0025","doi-asserted-by":"crossref","first-page":"f2023","DOI":"10.1136\/bmj.f2023","article-title":"Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study","volume":"346","author":"Vickers","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2014.08.010_bib0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1464-410X.2012.11329.x","article-title":"From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer","volume":"112","author":"Hori","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2014.08.010_bib0035","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.juro.2010.12.032","article-title":"A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng\/ml prostate specific antigen range","volume":"185","author":"Catalona","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.08.010_bib0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1373\/clinchem.2012.195784","article-title":"Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer","volume":"59","author":"Stephan","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.eururo.2014.08.010_bib0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.eururo.2011.10.038","article-title":"Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and Prostate Health Index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer","volume":"61","author":"Guazzoni","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.08.010_bib0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eururo.2011.03.052","article-title":"Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng\/ml: results of a prospective study in a clinical setting","volume":"60","author":"Guazzoni","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.08.010_bib0055","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eururo.2013.01.011","article-title":"Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng\/ml: a multicentric European study","volume":"63","author":"Lazzeri","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.08.010_bib0060","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2009.24.1968","article-title":"Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication","volume":"28","author":"Vickers","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.08.010_bib0065","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1158\/1078-0432.CCR-10-0122","article-title":"A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam","volume":"16","author":"Vickers","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2014.08.010_bib0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/1055-9965.EPI-10-1003","article-title":"A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening","volume":"20","author":"Vickers","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2014.08.010_bib0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1741-7015-6-19","article-title":"A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in G\u00f6teborg, Sweden","volume":"6","author":"Vickers","year":"2008","journal-title":"BMC Medicine"},{"key":"10.1016\/j.eururo.2014.08.010_bib0080","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/1471-2407-10-635","article-title":"A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer Screening, France","volume":"10","author":"Benchikh","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eururo.2014.08.010_bib0085","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1021\/ac061201+","article-title":"Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab\u2032) 2 fragments","volume":"78","author":"V\u00e4is\u00e4nen","year":"2006","journal-title":"Anal Chem"},{"key":"10.1016\/j.eururo.2014.08.010_bib0090","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eururo.2012.10.001","article-title":"Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, despite no recommendations for PSA screening: results from a population-based study, 2003\u20132011","volume":"63","author":"Nordstr\u00f6m","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.08.010_bib0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.eururo.2014.08.010_bib0100","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.eururo.2014.08.010_bib0105","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.eururo.2014.08.010_bib0110","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.eururo.2010.02.003","article-title":"Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection","volume":"57","author":"Jansen","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.08.010_bib0115","unstructured":"Team RDC. R: a language and environment for statistical computing. R Foundation for Statistical Computing Web site. http:\/\/www.R-project.org\/."},{"key":"10.1016\/j.eururo.2014.08.010_bib0120","unstructured":"Hybritech p2PSA draft directional insert. US Food and Drug Administration Web site. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf9\/P090026c.pdf."},{"key":"10.1016\/j.eururo.2014.08.010_bib0125","series-title":"Prostate cancer early detection","first-page":"1","author":"Carroll","year":"2014"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814007520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814007520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T01:02:10Z","timestamp":1668646930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283814007520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0302283814007520"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2014.08.010","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2014.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}